Page 74 - CIBERES-2015-eng

Research Groups
Group 21
Programme: COPD / Lung Cancer / Fibrosis / Pulmonary Hypertension Lead Researcher: Álvarez Martínez, Carlos José
Group members
STAFF MEMBERS: Castro Acosta, Ady Angelica | Fernández González, Saúl.
ASSOCIATED MEMBERS: Díaz de Atauri Rodríguez de los Ríos, Ma Josefa | Enguita Valls, Ana Belén | Gámez García, Antonio Pablo | García Luján, Ricardo | Gómez Sánchez, Miguel Ángel | Rami Porta, Ramón | Villena Garrido, Ma Victoria.
Main lines of research
• Line NEOPLASIAS TORÁCCICAS LUNG CANCER AND PLEURA: Identify a set of clinical-molecular variables that improve the prognostic and predic- tive capacity of TNM and clinical translation of these results.
• Line CHRONIC OBSTRUCTIVE PULMONARY DISEASE: To study the clinical, biological, micro- biological, radiological, functional determinants of progression and severity. Evaluate new endo- scopic treatment in obstructive airway disease and the impact of different approaches to health care in the management of disease activity.
• Line PULMONARY HYPERTENSION (HP): Estab- lish a network of groups with complementary capabilities of research aimed at identifying new markers for assessing disease activity and new therapeutic targets for the treatment of pulmo- nary hypertension following a strategy of transla-
•
•
•
tional research, with the ultimate aim of contribut- ing to alleviate and cure the disease.
Line INSTERSTICIALES DISEASES AND FIBRO- SIS: Create a record of well-characterized pa- tients, and incorporate new treatments in their care, measuring the impact on quality of life, pro- gression and prevention of exacerbations.
Line SAHS & NO INVASIVE VENTILATION (NIV): Develop new ways of simplified diagnosis, deep- en treatment indications and establish new in- dications for NIV outside the critical care units. Investigate the causes of failure of NIV and asyn- chrony.
Line RESEARCH IN LUNG TRANSPLANTATION: Advance knowledge of the causes of rejection and infection and diagnosis, and expand the se- lection criteria organ donor and recipient.
74 I Annual report 2015 I CIBERES